Distribution of HPV genotypes in uterine cervical lesions among the Uighur women in Xinjiang province of China

European Journal of Gynaecological Oncology

Volumn 31, Issue 3, 2010, Pages 315-318

  Abudukadeer, A ^a   Ding, Y ^a   Niyazi, M ^b   Ababaikeli, A ^a   Abudula, A ^a  

^a Medical University of Xinjiang   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Cervical cancer; CIN; HPV genotypes; Uighur population of Xinjiang

Indexed keywords

ADULT; AGED; ARTICLE; CHINA; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORBIDITY; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 77954106080     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Franco E.L., Schlecht N.F., Saslow D.: "The epidemiology of cervical cancer". Cancer J., 2003, 9, 348.
2. Parkin D.M., Bray F., Ferlay J., Pisani P.: "Estimating the world cancer burden: Globocan 2000". Int. J. Cancer, 2001, 94, 153.
3. Parkin D.M.: "Global cancer statistics in the year 2000". Lancet Oncol., 2001, 2, 533.
4. Ferlay J.B.F.P.P., Parkin D.M.: "GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide". IARC Cancer Base No. 5, version 2.0. IARC Press, 2004.
5. Suzuke L., Peng Y., Zhou K.: "The analysis of pathogenetic tendency of cervical cancer in various ethnic groups in Xinjiang". J. Xinjiang Med. University, 2006, 29, 569.
6. Guzalinuer A., Peng Z., Guo Y.: "HPV and its subtypes in the Han nationality in Sichuan and the northwestern region of Xinjiang Uygur southern region of cervical tissue of women differentially expressed". Chinese Journal of Microbiology and Immunology, 2004, 24, 402.
7. Villa LL.: "Human papillomaviruses and cervical cancer". Adv. Cancer Res., 1997, 71, 321.
8. Ho G.Y., Burk R.D., Klein S., Kadish A.S., Chang C.J., Palan P. et al.: "Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia". J. Nat. Cancer Inst., 1995, 87, 1365.
9. Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H.: "Classification of papillomaviruses". Virology, 2004, 324, 17.
10. Munoz N., Bosch F.X., de Sanjose S., Herrero R.,Castellsague X., Shah K.V. et al.: "Epidemiologic classification of human papillomavirus types associated with cervical cancer". N. Engl. J. Med., 2003, 348, 518. (Pubitemid 36159887)
11. Asato T., Maehama T., Nagai Y., Kanazawa K., Uezato H., Kariya K.: "A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping". J. Infect. Disease, 2004, 189, 1829.
12. Andersson S., Rylander E., Larson B., Sigurdardottir S., Backlund I., Sallstrom J. et al.: "Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing". Oncol. Rep., 2003, 10, 175.
13. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J., Vaccarella S. et al.: "Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis". Lancet, 2005, 366, 991.
14. Bosch F.X., Manos M.M., Muñoz N., Sherman M., Jansen A.M., Peto J. et al.: " Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group". J. Natl. Cancer Inst., 1995, 87, 796.
15. Muñoz N., Bosch F.X., de Sanjose S. et al.: "Epidemiologic classification of human papillomavirus types associated with cervical cancer". N. Engl. J. Med., 2003, 348, 518. (Pubitemid 36159887)
16. Bao Y.P., Li N., Smith JS., Qiao YL.: "Human papillomavirus type distribution in women from Asia: a meta-analysis". Int. J. Gynecol. Cancer, 2008, 18, 71.
17. Bao Y.P., Li N., Smith J.S., Qiao Y.L.: "Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis". Int. J. STD AIDS, 2008, 19, 106.
18. Ma C.L., Li Y.J., Zhang F.C., Wang G.Q., Zheng Y.J., Kai L.M. et al.: "Detection of HPV16 E6 gene in cervical tissues by quantitative polymerase chain reaction". Zhonghua Yi Xue Za Zhi., 2004, 84, 469.
19. Masumoto N., Fujii T., Ishikawa M., Mukai M., Ono A., Iwata T. et al.: "Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients". Gynecol. Oncol., 2004, 94, 509. (Pubitemid 39024561)
20. Silins I., Wang X., Tadesse A., Jansen KU., Schiller JT., Avall-Lundqvist E. et al.: "A population based study of cervical carcinoma and HPV infection in Latvia". Gynecol. Oncol., 2004, 93, 484.
21. Kjaer S.K., van den Brule A.J., Pauli G. et al.: "Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study". BMJ, 2002, 325, 572.
22. Schiffman M., Herrero R., Desalle R., Hildesheim A., Wacholder S., Rodriguez A.C. et al.: "The carcinogenicity of human papillomavirus types reflects viral evolution". Virology, 2005, 337, 76.
23. Dalstein V., Riethmuller D., Pretet J.L., Le Bail Carval K., Sautiere J.L., Carbillet J.P. et al.: "Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study". Int. J. Cancer, 2003, 106, 396.
24. van Duin M., Snijders P.J., Schrijnemakers H.F., Voorhorst F.J., Rozendaal L., Nobbenhuis M.A. et al.: "Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance". Int. J. Cancer, 2002, 98, 590.
25. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B. et al.: "A controlled trial of a human papillomavirus type 16 vaccine". N. Engl. J. Med., 2002, 347, 1645.
26. Paavonen J., Jenkins D., Bosch F.X., Naud P., Salmerón J., Wheeler C.M. et al.: "Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial". Lancet, 2007, 369, 2161.
27. Bulkmans N.W., Rozendaal L., Voorhorst F.J., Snijders P.J., Meijer C.J.: "Long-term protective effect of high risk human papillomavirus testing in population-based cervical screening". Br. J. Cancer, 2005, 92, 1800.
28. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R. et al.: "The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of typespecific HPV testing in clinical practice". J. Natl. Cancer Inst., 2005, 97, 10729.
29. Liu J., Rose B., Huang X., Liao G.., Carter J., Wu X. Thompson C: "Comparative analysis of characteristics of women with cervical cancer in high-versus low-incidence regions". Gynecol. Oncol., 2004, 94, 803.
30. Wall S.R., Scherf C.F., Morison L., Hart K.W., West B., Ekpo G. et al.: "Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology". Br. J. Cancer, 2005, 93, 1068.